RISK WATCHBenzinga • 6d ago
Greenland Mines Registers To Sell 1.4M Shares Of Common Stock For Holders-SEC Filing
Why GRML Stock dropped -10.89% Today — RQD Quant Desk Flash
$4.58 -10.89% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $4.48
Greenland Mines Ltd. (GRML) carries a Roarable Rating of E (Strong Sell) with 32/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE E • RED ALERT
Cap $70.3M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on GRML Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is GRML stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, Greenland Mines Ltd. (NASDAQ: GRML) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $4.58 (-10.89% 1D, market cap $70.3M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, GRML ranks #780 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does GRML compare to CGTX and CRDF in the Health Care sector?
▼
Within the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)), GRML carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, CGTX (Cognition Therapeutics Inc.) holds a D- grade (43/100 RQD, P/E N/A, ROIC -35.0%, cap $70.3M) and CRDF (Cardiff Oncology Inc.) posts a D- grade (41/100 RQD, P/E N/A, ROIC -35.0%, cap $70.9M). Among the 5-stock peer group, GRML leads on earnings multiple (N/A) while CSBR leads on capital efficiency (-26.9% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for GRML?
▼
Per GRML's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001907223), Greenland Mines Ltd. generated $0 in revenue, -$10.6M in net income, and -$5.9M in free cash flow against $9.6M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $4.48 (-2.15%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 6/20 (E) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (32/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-9.2% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • E
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk D
Each axis scored 0–20
12M PRICE TARGET CONE-11.8% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for GRML)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (32/100 Composite)
🔍 WHY GRML SCORES 32/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+10/20 pts (31% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 2/9
▲ #2 Bullish Driver: Macro Regime Fit+8/20 pts (25% of score)
FRED Regime × Technicals: 5% of 52W Range • RSI-14 at 39 (NEUTRAL RANGE)
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$5.17+16.1% Next Q
40
Q2 (-2Q)Grade E$6.00-3.7% Next Q
37
Q3 (-1Q)Grade E$5.78-20.8% Next Q
35
CurrentGrade E$4.58-9.2% Hist 90D α
32
Trajectory: D (40) → E (32)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a GRML Turnaround Squeeze
While GRML currently carries a cautious 32/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($6.60) and Max Pain ($4.81) forces dealer call-delta covering toward $38.85.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $GRML• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “GRML Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why GRML Stock dropped -10.89% Today — RQD Quant Desk Flash
Greenland Mines Ltd. (GRML) dropped -10.89% to $4.58, trading at 5% of its 52-week range ($2.82 – $37). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 5% of its 52-week range ($2.82 – $37) with RSI-14 at 39 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $4.58 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 52% gross margin and $0 annual free cash flow.
Live GRML Headlines & Catalysts
MARKET WIREYahoo • 12d ago
Greenland Mines (GRML) Begins Trading on Xetra to Expand Global Investor AccessLOS ANGELES, CA - October 20, 2026 (NEWMEDIAWIRE) - Greenland Mines (NASDAQ: GRML) (FSE: HK6), a Greenland-focused critical-minerals developer, announced that its common stock has begun trading on Xetra, the electronic t
MARKET WIREYahoo • 13d ago
Greenland Mines Shares Begin Trading on Xetra in GermanyNasdaq-listed critical-minerals developer extends trading access to Deutsche Börse's primary electronic marketplaceXetra network connects trading participants across Europe, Hong Kong and the Middle East, broadening Gree
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring GRML)
- ✓Walkthrough of GRML's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
GRML // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -81.00%📐 HORIZONTAL RANGE
2026-10-30O $5.00H $5.00L $4.35C $4.58VOL 1.36M
RES: $18.74SUP: $-0.50SMA50: $6.60SMA200: $13.74
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
GRML Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on GRML today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for GRML. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for GRML today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (GRML)
Health Care Rank #780 of 1016
⚔️ CGTX vs GRML Full Matrix →
1. Head-to-Head Health Care Peer Comparison (GRML vs. CGTX, CRDF, NMRA, CSBR)
Industry: Biotechnology: Biological Products (No Diagnostic Substances) (156 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Greenland Mines Ltd. (GRML) ranks #780 by composite RQD confidence (32/100, grade E) and #706 by equity capitalization ($70.3M). Within this direct 5-issuer industry benchmark cohort, GRML leads on earnings valuation at N/A trailing P/E, while CSBR leads on capital efficiency and profitability with -26.9% ROIC and 48.0% gross margin. CGTX currently holds the highest overall quantitative score in the immediate peer group at 43/100 (D-) compared with GRML at 32/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| GRML
ACTIVE
Greenland Mines Ltd. | E | 32/100 | — | — | -35.0% | -10.89% | $70.3M | Benchmark Subject |
| CGTX Cognition Therapeutics Inc. | D- | 43/100 | — | — | -35.0% | -5.57% | $70.3M | /cgtx-vs-grml → |
| CRDF Cardiff Oncology Inc. | D- | 41/100 | — | — | -35.0% | -2.46% | $70.9M | /crdf-vs-grml → |
| NMRA Neumora Therapeutics Inc. | D- | 42/100 | — | — | -35.0% | -5.43% | $73.0M | /nmra-vs-grml → |
| CSBR Champions Oncology Inc. | E | 22/100 | — | 48.0% | -26.9% | 0.00% | $66.9M | /csbr-vs-grml → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001907223In its most recent audited fiscal period (FY2025, filed 2025-12-31), Greenland Mines Ltd. (GRML) reported GAAP revenue of $0 (N/A vs. FY2024 revenue of $0 ) , GAAP net income of -$10.6M, operating cash flow of -$5.9M, and free cash flow of -$5.9M (-99.9% YoY). On the balance sheet, GRML closed FY2025 with $9.6M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $0 | -$10.6M | -$5.9M | -$5.9M | $9.6M | — |
| FY2024 (FY) | 2024-12-31 | $0 | -$6.2M | -$2.9M | -$2.9M | $2.5M | — |
| FY2023 (FY) | 2023-12-31 | $0 | -$707.5K | -$446.9K | -$446.9K | — | — |
3. GRML Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs GRML stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, Greenland Mines Ltd. (NASDAQ: GRML) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 32/100 at a spot price of $4.58 (-10.89% 1D, market cap $70.3M). Pillar breakdown: Fundamental Cash Engine 6/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 8/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, GRML ranks #780 in composite RQD confidence.
How does GRML compare to CGTX and CRDF in the Health Care sector?
Within the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)), GRML carries a Roarable E (32/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, CGTX (Cognition Therapeutics Inc.) holds a D- grade (43/100 RQD, P/E N/A, ROIC -35.0%, cap $70.3M) and CRDF (Cardiff Oncology Inc.) posts a D- grade (41/100 RQD, P/E N/A, ROIC -35.0%, cap $70.9M). Among the 5-stock peer group, GRML leads on earnings multiple (N/A) while CSBR leads on capital efficiency (-26.9% ROIC).
What are the biggest fundamental strengths and SEC risk factors for GRML?
Per GRML's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001907223), Greenland Mines Ltd. generated $0 in revenue, -$10.6M in net income, and -$5.9M in free cash flow against $9.6M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is GRML trading relative to its 50-day, 200-day, and 52-week technical levels?
GRML last traded at $4.58 (-10.89% on volume of 1,359,728 shares), positioning the stock -30.61% below its 50-day simple moving average ($6.60) and -66.67% below its 200-day simple moving average ($13.74). Across its 52-week range of $2.82 to $37.00, GRML sits at the 5.1% percentile with a 14-day RSI of 39.0 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($4.01 to $5.15).
GRML Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is GRML stock moving today?
Why GRML Stock dropped -10.89% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.